Profile data is unavailable for this security.
About the company
Croda International PLC is a United Kingdom-based consumer care and life sciences focused company. The Company operates through two segments: Consumer Care, and Life Sciences. The Consumer Care segment is focused on high-value niches in the markets of skin care, hair care, solar protection, fabric and surface care, and fragrances. The Consumer Care comprises four businesses: beauty care, beauty actives, home care, and fragrances and flavors. The Company's Life Sciences segment comprises three businesses, including patient health, consumer and veterinary health, crop protection, and seed enhancement. It is engaged in leveraging in-house developed and acquired technologies, building scale for the delivery of customers’ drug, vaccine, and crop science products.
- Revenue in GBP (TTM)1.89bn
- Net income in GBP320.80m
- Incorporated1925
- Employees6.14k
- LocationCroda International PlcCowick HallGOOLE DN14 9AAUnited KingdomGBR
- Phone+44 140 586 0551
- Fax+44 140 586 1767
- Websitehttps://www.croda.com/en-gb
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orion Oyj | 895.48m | 164.34m | 5.29bn | 3.38k | 32.14 | 9.61 | 26.37 | 5.91 | 1.36 | 1.36 | 7.41 | 4.55 | 0.8654 | 1.66 | 6.05 | 310,849.50 | 15.90 | 18.94 | 24.31 | 23.82 | 57.92 | 59.52 | 18.37 | 19.89 | 1.08 | 2,397.00 | 0.1709 | 101.61 | -3.44 | -0.613 | -11.87 | -4.89 | 12.25 | -0.6537 |
| Swedish Orphan Biovitrum AB (publ) | 1.34bn | 201.01m | 5.44bn | 1.57k | 26.20 | 2.77 | 13.81 | 4.07 | 8.49 | 8.49 | 56.55 | 80.49 | 0.3462 | 1.33 | 4.74 | 10,771,650.00 | 5.20 | 8.45 | 6.50 | 10.61 | 74.55 | 76.41 | 15.03 | 21.08 | 0.6623 | 8.18 | 0.2915 | 0.00 | 1.76 | 24.44 | -17.44 | 27.31 | 17.53 | -- |
| DiaSorin SpA | -85.86bn | -85.86bn | 6.35bn | 3.36k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 16.63 | -- | 19.02 | -- | 67.86 | -- | 24.99 | -- | -- | -- | 25.24 | 40.43 | 16.80 | 25.46 | 22.58 | 25.68 | 5.59 |
| Ipsen SA | 2.58bn | 554.85m | 6.50bn | 5.74k | 11.65 | 2.71 | 8.57 | 2.52 | 7.75 | 7.75 | 35.98 | 33.29 | 0.6436 | 2.48 | 5.76 | 522,127.40 | 13.87 | 9.53 | 18.81 | 13.46 | 82.06 | 81.50 | 21.55 | 14.05 | 1.41 | 41.24 | 0.2011 | 22.45 | 11.65 | 12.41 | 18.82 | 23.42 | 2.81 | 7.14 |
| Grifols SA | 4.24bn | 162.05m | 8.98bn | 23.23k | 63.42 | 2.16 | 16.73 | 2.12 | 0.2769 | 0.2769 | 7.22 | 8.14 | 0.2859 | 1.39 | 10.34 | 212,332.40 | 1.54 | 4.23 | 2.02 | 5.15 | 39.78 | 44.51 | 5.38 | 12.07 | 0.9357 | 4.50 | 0.5691 | 26.75 | -7.62 | 4.02 | -71.29 | -19.12 | 1.49 | -- |
| Qiagen NV | 1.93bn | 450.55m | 9.19bn | 6.00k | 20.89 | 3.41 | 14.63 | 4.75 | 2.27 | 2.27 | 9.73 | 13.88 | 0.3872 | 2.56 | 6.10 | 373,741.90 | 9.02 | 3.69 | 10.27 | 4.28 | 64.65 | 65.54 | 23.29 | 11.68 | 1.85 | 196.99 | 0.375 | -- | 20.39 | 10.97 | 42.71 | 44.84 | 17.07 | -- |
| Croda International Plc | 1.89bn | 320.80m | 9.47bn | 6.14k | 29.55 | 5.40 | 21.71 | 5.01 | 2.29 | 2.29 | 13.52 | 12.57 | 0.5978 | 2.55 | 6.02 | 308,003.30 | 10.21 | 11.17 | 11.75 | 13.16 | 49.69 | 43.71 | 17.08 | 16.39 | 0.98 | 23.60 | 0.3464 | 61.78 | 35.91 | 8.73 | 59.13 | 10.28 | 8.53 | 5.70 |
| Vifor Pharma AG | 1.51bn | 126.59m | 9.68bn | 2.30k | 76.60 | 3.21 | 23.83 | 6.39 | 2.25 | 2.22 | 26.98 | 53.78 | 0.3403 | 1.96 | 3.78 | 762,695.60 | 5.15 | 4.77 | 6.75 | 6.30 | 61.70 | 59.81 | 15.13 | 13.94 | 1.56 | -- | 0.132 | 102.79 | 2.85 | 8.49 | 5.70 | -0.0681 | -2.52 | 0.00 |
| BioMerieux SA | 2.90bn | 516.13m | 10.12bn | 13.08k | 19.47 | 3.73 | 14.00 | 3.49 | 5.06 | 5.06 | 28.42 | 26.40 | 0.7903 | 2.40 | 5.68 | 258,198.20 | 14.02 | 9.78 | 18.25 | 13.13 | 58.16 | 55.47 | 17.74 | 12.69 | 1.64 | 67.03 | 0.1272 | 14.14 | 8.27 | 9.93 | 48.64 | 27.40 | 4.48 | 20.59 |
| Eurofins Scientific SE | 5.77bn | 865.94m | 12.06bn | 57.99k | 14.52 | 3.02 | 8.95 | 2.09 | 5.03 | 3.73 | 33.49 | 24.18 | 0.7503 | 30.95 | 5.20 | 115,838.40 | 11.65 | 7.66 | 14.59 | 9.73 | 28.31 | 23.52 | 15.53 | 11.80 | 1.17 | 14.16 | 0.3706 | 16.22 | 23.51 | 21.50 | 50.07 | 39.88 | 21.07 | 37.97 |
| UCB SA | 4.96bn | 905.87m | 13.80bn | 8.56k | 15.20 | 1.86 | 11.65 | 2.78 | 5.43 | 5.45 | 29.75 | 44.33 | 0.4197 | 1.66 | 5.09 | 674,804.40 | 7.67 | 7.39 | 9.65 | 9.30 | 75.11 | 74.34 | 18.28 | 16.73 | 1.00 | 22.50 | 0.202 | 28.56 | 8.04 | 6.85 | 44.13 | 14.21 | 29.00 | 2.48 |
Data as of Jul 06 2022. Currency figures normalised to Croda International Plc's reporting currency: UK Pound GBX
30.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Mawer Investment Management Ltd.as of 31 Dec 2021 | 6.44m | 4.61% |
| RBC Global Asset Management (UK) Ltd.as of 20 Jan 2022 | 4.94m | 3.54% |
| Royal London Asset Management Ltd.as of 02 Jun 2022 | 4.57m | 3.27% |
| Massachusetts Financial Services Co.as of 17 Jun 2022 | 4.54m | 3.25% |
| BlackRock Fund Advisorsas of 02 Jun 2022 | 4.26m | 3.05% |
| Norges Bank Investment Managementas of 14 Jan 2022 | 4.19m | 3.00% |
| The Vanguard Group, Inc.as of 02 Jun 2022 | 4.15m | 2.97% |
| MFS International (UK) Ltd.as of 02 Jun 2022 | 3.77m | 2.70% |
| Impax Asset Management Ltd.as of 02 Jun 2022 | 3.15m | 2.26% |
| Legal & General Investment Management Ltd.as of 02 Jun 2022 | 2.23m | 1.60% |
More ▼
Data from 31 Dec 2021 - 31 May 2022Source: FactSet Research Systems Inc.
